These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 9450159

  • 1. Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia.
    Pizzolato G, Cagnin A, Mancia D, Caffarra P, Avanzi S, Copelli S, Ciappina C, Lo Presti F, Spilimbergo PG, D'Antonio E, Di Costanzo E, Matrango M, Pastres P, Urbani PP, Signorino M, Simoncelli M, Provinciali L, Regnicolo L, Albano C, Roccatagliata G, Rubino V, Cultrera S, Fracassi M.
    Arzneimittelforschung; 1997 Nov; 47(11A):1329-31. PubMed ID: 9450159
    [Abstract] [Full Text] [Related]

  • 2. Role of pivagabine in the treatment of climacteric syndrome.
    Gigliotti B, Multinu A, Lai VR.
    Arzneimittelforschung; 1997 Nov; 47(11A):1317-21. PubMed ID: 9450156
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the efficacy of pivagabine on insomnia associated with mood disorders.
    Negri L.
    Arzneimittelforschung; 1997 Nov; 47(11A):1322-5. PubMed ID: 9450157
    [Abstract] [Full Text] [Related]

  • 4. Use of pivagabine in the management of hospitalization distress in children.
    Gelsomini S.
    Arzneimittelforschung; 1997 Nov; 47(11A):1332-5. PubMed ID: 9450160
    [Abstract] [Full Text] [Related]

  • 5. Clinical evaluation of the efficacy of pivagabine in the treatment of mood and adjustment disorders.
    Terranova R, Gilotta SM, Luca S.
    Arzneimittelforschung; 1997 Nov; 47(11A):1325-8. PubMed ID: 9450158
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia.
    Tang W, Gao Y, Chen G, Gao H, Dai X, Ye J, Chan E, Huang M, Zhou S.
    J Med Food; 2005 Nov; 8(1):53-8. PubMed ID: 15857210
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of pivagabine on stress-induced gastric ulcer formation in rats.
    Gianni AM, Bruno G, Sirtori C.
    Arzneimittelforschung; 1997 Nov; 47(11A):1315-7. PubMed ID: 9450155
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of pivagabine on psychophysical performance and behavioural response in experimental models of stress.
    Scapagnini U, Matera M.
    Arzneimittelforschung; 1997 Nov; 47(11A):1310-4. PubMed ID: 9450154
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.
    Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Judd F, Katz F, Katz P, Ording-Jespersen S, Little J, Conus P, Cuenod M, Do KQ, Bush AI.
    Biol Psychiatry; 2008 Sep 01; 64(5):361-8. PubMed ID: 18436195
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.
    Eur Neuropsychopharmacol; 2008 Nov 01; 18(11):803-13. PubMed ID: 18694635
    [Abstract] [Full Text] [Related]

  • 17. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec 01; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of bis-(isobutyryloxy-2-ethyl)-1-N-(amino-4-methyl-2-pyrimidyl-5) methyl formamido-2-propene-1-yl disulfide (Sulbutiamin) in neurasthenic and neuroastheniform syndromes].
    Balestreri R, Bertolini S, Barban G, Montanari D, Jacopino JE, Chiodini G, Reggiani E.
    Arch Maragliano Patol Clin; 1979 Dec 01; 35():19-34. PubMed ID: 400511
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.